Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 324 articles:
HTML format



Single Articles


    June 2022
  1. IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
    NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Int J Cardiol. 2022;357:48-54.
    PubMed     Abstract available


  2. QIAN Z, Qin C, Zou F, Xue S, et al
    Complete electrical reverse remodeling of native conduction after resynchronization therapies.
    Int J Cardiol. 2022;357:81-87.
    PubMed     Abstract available


  3. SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
    Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
    Int J Cardiol. 2022;357:95-104.
    PubMed     Abstract available


  4. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
    Int J Cardiol. 2022;356:98-104.
    PubMed     Abstract available


  5. SABATINO J, Di Salvo G
    The new pandemic: ACHD HF.
    Int J Cardiol. 2022;356:51-52.
    PubMed    


    May 2022
  6. STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
    Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;355:65-71.
    PubMed     Abstract available


  7. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
    Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
    PubMed     Abstract available


  8. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
    Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
    PubMed     Abstract available


    April 2022
  9. FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
    Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
    Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
    PubMed     Abstract available


  10. BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
    Sex-related differences among young adults with heart failure in Sweden.
    Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
    PubMed     Abstract available


  11. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    PubMed     Abstract available


  12. YU X
    Heart failure with improved ejection fraction: The current and future in Asian populations.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.
    PubMed    


  13. CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
    Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
    PubMed     Abstract available


  14. LI L, Zhang Z, Xiong Y, Hu Z, et al
    Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
    PubMed     Abstract available


  15. BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
    A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
    PubMed     Abstract available


  16. CASTIGLIONE V, Vergaro G, Emdin M
    Targeting precipitants to prevent heart failure hospitalization. Does season matter?
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
    PubMed    


  17. RIZZO M, Cianflone D, Maranta F
    Treatment of diabetes and heart failure: Facts and hopes.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
    PubMed    


  18. ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
    Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
    Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
    PubMed     Abstract available


  19. SHOJI S, Kohsaka S, Shiraishi Y, Kohno T, et al
    Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
    Int J Cardiol. 2022 Apr 11. pii: S0167-5273(22)00500.
    PubMed     Abstract available


  20. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed     Abstract available


  21. ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
    Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
    PubMed     Abstract available


  22. FERREIRA JP, Shah AM, Claggett BL, Pitt B, et al
    Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.
    Int J Cardiol. 2022;352:78-83.
    PubMed     Abstract available


    March 2022
  23. SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
    Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
    Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
    PubMed     Abstract available


  24. SU K, Li M, Wang L, Tian S, et al
    Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
    Int J Cardiol. 2022 Mar 23. pii: S0167-5273(22)00405.
    PubMed     Abstract available


  25. SATO T, Kobayashi Y, Nagai T, Nakatani T, et al
    Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
    Int J Cardiol. 2022 Mar 22. pii: S0167-5273(22)00403.
    PubMed     Abstract available


  26. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    PubMed    


  27. ESPERSEN C, Modin D, Platz E, Jensen GB, et al
    Global and regional wall motion abnormalities and incident heart failure in the general population.
    Int J Cardiol. 2022 Mar 15. pii: S0167-5273(22)00386.
    PubMed     Abstract available


  28. AIMO A, Lupon J, Bayes-Genis A, Emdin M, et al
    Urinary NGAL in acute heart failure revisited: the game is not over yet.
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00382.
    PubMed    


  29. MINISTRINI S
    Could serum carboxyterminal telopeptide of collagen type I (CITP) have a role in the early diagnosis of heart failure with preserved ejection fraction (HFpEF)?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00383.
    PubMed    


  30. JAYAGOPAL PB, Sastry SL, Nanjappa V, Abdullakutty J, et al
    Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).
    Int J Cardiol. 2022 Mar 13. pii: S0167-5273(22)00381.
    PubMed     Abstract available


  31. BRIDA M, Lovric D, Griselli M, Gil FR, et al
    Heart failure in adults with congenital heart disease.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00337.
    PubMed     Abstract available


  32. BILLINGSLEY HE, Canada JM, Dixon DL, Kirkman DL, et al
    Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
    Int J Cardiol. 2022 Mar 8. pii: S0167-5273(22)00330.
    PubMed     Abstract available


    February 2022
  33. HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Decongestion, kidney injury and prognosis in patients with acute heart failure.
    Int J Cardiol. 2022 Feb 21. pii: S0167-5273(22)00261.
    PubMed     Abstract available


  34. CHIANG B, Chew DP, De Pasquale CG
    Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective.
    Int J Cardiol. 2022;349:96-98.
    PubMed     Abstract available


  35. TINI G, Cuomo A, Battistoni A, Sarocchi M, et al
    Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
    Int J Cardiol. 2022;349:134-137.
    PubMed     Abstract available


  36. ROJAS LZ, Gomez-Ochoa SA, Echeverria LE, Bautista-Nino PK, et al
    Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study.
    Int J Cardiol. 2022;349:90-95.
    PubMed     Abstract available


  37. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    PubMed     Abstract available


  38. DURAN A, De Anda-Duran I, Ventura HO
    The era of heart failure risk prediction models, is it time to test their utility?
    Int J Cardiol. 2022 Feb 9. pii: S0167-5273(22)00218.
    PubMed    


  39. CHARANSONNEY OL
    SGLT-2 inhibitors in frail patients with heart failure.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00193.
    PubMed    


  40. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    PubMed    


  41. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    PubMed     Abstract available


  42. TRAMBAIOLO P, Figliuzzi I, Salvati M, Bertini P, et al
    Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter.
    Int J Cardiol. 2022;348:85-89.
    PubMed     Abstract available


  43. AHMED S, Ahmed A, Radegran G
    The Authors' Reply to the Letter "Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis".
    Int J Cardiol. 2022;348:108.
    PubMed    


    January 2022
  44. ROVAI S, Contini M, Sciomer S, Vignati C, et al
    The double anaerobic threshold in heart failure.
    Int J Cardiol. 2022 Jan 25. pii: S0167-5273(22)00136.
    PubMed     Abstract available


  45. DONAL E, L'official G, Kosmala W
    New guidelines for managing chronic heart failure patients and new needs in echocardiography.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00125.
    PubMed    


  46. SCRUTINIO D, Guida P, Passantino A, Scalvini S, et al
    Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00129.
    PubMed     Abstract available


  47. CHANG GM, Chen JY, Kuo WY, Tung YC, et al
    Associations of continuity and coordination of care with outcomes and costs after discharge among patients with heart failure: A nationwide population-based study.
    Int J Cardiol. 2022 Jan 19. pii: S0167-5273(22)00118.
    PubMed     Abstract available


  48. ZHENG H, Liang J, Chen X, Chen X, et al
    Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis.
    Int J Cardiol. 2022;347:64-65.
    PubMed    


  49. CARLUCCIO E, Dini FL, Bitto R, Ciccarelli M, et al
    Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00004.
    PubMed     Abstract available


  50. GIANNONI A, Sciarrone P
    Prognostic impact of diabetes in heart failure: looking back to move forward.
    Int J Cardiol. 2022 Jan 4. pii: S0167-5273(22)00005.
    PubMed    


    December 2021
  51. DRISCOLL A, Romanuick H, Dinh D, Amerena J, et al
    Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02053.
    PubMed     Abstract available


  52. GIACCARI A, Pontremoli R, Filardi PP
    SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02054.
    PubMed     Abstract available


  53. RIND IA, Cannata A, McDonaugh B, Cassimon B, et al
    Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes.
    Int J Cardiol. 2021 Dec 29. pii: S0167-5273(21)02045.
    PubMed     Abstract available


  54. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    PubMed     Abstract available


  55. BHATIA HS, Nishimura M, Martinez A, Vanam S, et al
    Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02016.
    PubMed     Abstract available


  56. ANABA U, Ishola A, Alabre A, Bui A, et al
    Diversity in modern heart failure trials: Where are we, and where are we going.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)02010.
    PubMed     Abstract available


  57. BALBI C
    Editorial: Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01995.
    PubMed    


  58. GUAZZI M, Bursi F, Rusconi F
    Lung Biomarkers: a new route for distinguishing pulmonary hypertension due to HFpEF from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01982.
    PubMed    


  59. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    PubMed     Abstract available


  60. SARDU C, Amarelli C
    Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
    Int J Cardiol. 2021;344:138-139.
    PubMed    


  61. LIANG Y, Ding R, Wang J, Gong X, et al
    Prediction of response after cardiac resynchronization therapy with machine learning.
    Int J Cardiol. 2021;344:120-126.
    PubMed     Abstract available


    November 2021
  62. KRIM SR
    Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01952.
    PubMed    


  63. OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
    Heart failure among US nursing home residents with diabetes mellitus.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
    PubMed     Abstract available


  64. KITAI T
    Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
    Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.
    PubMed    


  65. REA F, Iorio A, Barbati G, Bessi R, et al
    Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.
    PubMed    


  66. FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
    Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
    PubMed     Abstract available


  67. LAMMERS AE, Sprenger KS, Diller GP, Miera O, et al
    Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
    Int J Cardiol. 2021;343:37-44.
    PubMed     Abstract available


  68. GORI M, Marini M, De Maria R, Gonzini L, et al
    Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
    Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
    PubMed     Abstract available


  69. MO M, Xia N, Liao Y
    Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
    Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
    PubMed    


  70. TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
    Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
    PubMed     Abstract available


  71. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    PubMed     Abstract available


  72. UDANI K, Chris-Olaiya A, Ohadugha C, Malik A, et al
    Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.
    Int J Cardiol. 2021;342:117-124.
    PubMed     Abstract available


  73. FASTNER C, Yuecel G, Rudic B, Schmiel G, et al
    Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.
    Int J Cardiol. 2021;342:49-55.
    PubMed     Abstract available


    October 2021
  74. BIEGUS J, Nawrocka-Millward S, Zymlinski R, Fudim M, et al
    Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
    Int J Cardiol. 2021 Oct 30. pii: S0167-5273(21)01703.
    PubMed     Abstract available


  75. AHMED S, Ahmed A, Radegran G
    Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
    PubMed     Abstract available


  76. HE Z, Yang L, Nie Y, Wang Y, et al
    Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Oct 12. pii: S0167-5273(21)01562.
    PubMed     Abstract available


  77. YOUN JC, Baek SH
    Heart failure risk in younger adults needing more attention.
    Int J Cardiol. 2021 Oct 8. pii: S0167-5273(21)01560.
    PubMed    


  78. ARENJA N, Mueller C, Tomilovskaya E, Koryak Y, et al
    Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01504.
    PubMed     Abstract available


  79. DARDEN D, Ammirati E, Brambatti M, Lin A, et al
    Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices: insights from TRAViATA.
    Int J Cardiol. 2021;340:26-33.
    PubMed     Abstract available


    September 2021
  80. MIRO O, Llorens P, Freund Y, Davison B, et al
    Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
    Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01470.
    PubMed     Abstract available


  81. DLOUHA D, Ivak P, Netuka I, Novakova S, et al
    The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels.
    Int J Cardiol. 2021;339:138-143.
    PubMed     Abstract available


  82. WEBER C, Hung J, Hickling S, Li I, et al
    Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016.
    Int J Cardiol. 2021 Sep 11. pii: S0167-5273(21)01376.
    PubMed     Abstract available


  83. KAPELIOS CJ, Canepa M, Benson L, Hage C, et al
    Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01334.
    PubMed     Abstract available


  84. GUIMARAES GV, Ribeiro F, Castro RE, Roque JM, et al
    Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2021 Sep 7. pii: S0167-5273(21)01318.
    PubMed     Abstract available


  85. AMARELLI C, Limongelli G
    Cardiac amyloidosis: Watching the tip of the iceberg emerging from the "heart of the sea".
    Int J Cardiol. 2021;338:226-228.
    PubMed    


  86. BODE N, Hochadel M, Andresen D, Zahn R, et al
    Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry.
    Int J Cardiol. 2021;338:109-114.
    PubMed     Abstract available


    August 2021
  87. MONZO L, Ferrari I, Cicogna F, Tota C, et al
    Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01301.
    PubMed     Abstract available


  88. KANEKO H, Itoh H, Kamiya K, Morita K, et al
    Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01307.
    PubMed     Abstract available


  89. NAKAO K, Yasuda S, Noguchi T, Sumita Y, et al
    Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
    Int J Cardiol. 2021 Aug 19. pii: S0167-5273(21)01229.
    PubMed     Abstract available


  90. VINTER N, Frost L, Benjamin EJ
    Heart failure and atrial fibrillation - does heart failure subtype matter?
    Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
    PubMed    


  91. TADA A, Nagai T, Omote K, Iwano H, et al
    Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
    PubMed     Abstract available


    July 2021
  92. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available


  93. ABBOUD A, Gaggin HK
    Heart failure and frailty: Expanding the gender paradox.
    Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01190.
    PubMed    


  94. ZHOU Y, Chen S, Rao Z, Yang D, et al
    Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China.
    Int J Cardiol. 2021 Jul 13. pii: S0167-5273(21)01169.
    PubMed     Abstract available


  95. NJI MAM, Solomon SD, Chen LY, Shah AM, et al
    Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
    PubMed     Abstract available


  96. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
    Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
    Int J Cardiol. 2021;334:148-153.
    PubMed     Abstract available


    June 2021
  97. DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
    Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
    Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
    PubMed     Abstract available


  98. ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
    Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
    Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
    PubMed     Abstract available


  99. DURAN A, daSilva-deAbreu A, Joury A, Ventura HO, et al
    FGF23 predicts outcomes in heart failure but questions remain unanswered.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01034.
    PubMed    


  100. ILONZE OJ, Guglin M
    Vericiguat, organic nitrates, and heart failure in African Americans.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01031.
    PubMed     Abstract available


  101. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    PubMed     Abstract available


  102. KEULARDS DCJ, Bouwmeester S, de Vos AMJ, Dekker LRC, et al
    High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study.
    Int J Cardiol. 2021;333:21-28.
    PubMed     Abstract available


  103. DASILVA-DEABREU A, Lavie CJ, Mehra MR
    Bridging the palliative care chasm in advanced heart failure.
    Int J Cardiol. 2021 Jun 15. pii: S0167-5273(21)00969.
    PubMed    


  104. WANG M, Luo B
    Levosimendan is safe to patients with advanced heart failure and hypotension.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00914.
    PubMed    


  105. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
    Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
    Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
    PubMed     Abstract available


  106. LIU L, Lima JAC, Post WS, Szklo M, et al
    Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
    PubMed     Abstract available


  107. POTRATZ M, Fox H, Rudolph V, Faber L, et al
    Respiratory dyssynchrony is a predictor of prognosis in patients with hypertrophic non-obstructive cardiomyopathy.
    Int J Cardiol. 2021;332:105-112.
    PubMed     Abstract available


    May 2021
  108. AIMO A
    Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00839.
    PubMed    


  109. VERGARO G, Aimo A, Taurino E, Del Franco A, et al
    Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00840.
    PubMed     Abstract available


  110. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    PubMed     Abstract available


  111. GALLI E, Smiseth OA MD, PhD, Aalen JM, Larsen CK, et al
    Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2021;331:144-151.
    PubMed     Abstract available


  112. MACGOWAN GA, Woods A, Robinson-Smith N, Tovey S, et al
    Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.
    Int J Cardiol. 2021;331:35-39.
    PubMed     Abstract available


  113. SHARIATI F, Baldawi H, Bob-Manuel T
    Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales.
    Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00838.
    PubMed    


  114. KAMIYA K, Adachi T, Iwatsu K, Kamisaka K, et al
    Association between a pre-admission limitation in walking ability and post-discharge adverse outcomes among hospitalized patients with heart failure: Report from a multicenter prospective cohort study.
    Int J Cardiol. 2021 May 12. pii: S0167-5273(21)00832.
    PubMed     Abstract available


  115. SACCO A, Morici N, Villanova L, Viola G, et al
    Withdrawal of active treatments in terminally ill heart failure patients.
    Int J Cardiol. 2021 May 5. pii: S0167-5273(21)00815.
    PubMed     Abstract available


  116. KLEIN HU
    Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
    Int J Cardiol. 2021;330:82-83.
    PubMed    


    April 2021
  117. SCHREUDER MM, Schuurman A, Akkerhuis KM, Constantinescu AA, et al
    Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 30. pii: S0167-5273(21)00804.
    PubMed     Abstract available


  118. GORI M, Claggett B, Senni M, Shah AM, et al
    Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00664.
    PubMed     Abstract available


  119. AIMO A, Manetti S, Emdin M
    How much is it to mend a broken heart? Results from the US Nationwide Readmission Database.
    Int J Cardiol. 2021;329:150-151.
    PubMed    


  120. MCGEE M, Sugito S, Al-Omary MS, Hartnett D, et al
    Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales.
    Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00637.
    PubMed     Abstract available


  121. LI X, Zhang Q, Zhu L, Wang G, et al
    Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2021 Apr 7. pii: S0167-5273(21)00636.
    PubMed     Abstract available


  122. CAO M, Stolen CM, Ahmed R, Schloss EJ, et al
    Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator.
    Int J Cardiol. 2021 Apr 1. pii: S0167-5273(21)00632.
    PubMed     Abstract available


  123. QAMRUDDIN S, Ventura HO
    Serial echocardiographic parameters to evaluate prognosis in patients with HFrEF - is it worth the second test?
    Int J Cardiol. 2021;328:141-142.
    PubMed    


  124. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    PubMed     Abstract available


  125. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    PubMed     Abstract available


    March 2021
  126. JACKSON AO, Rahman GA, Long S
    Attenuating senescence and dead cells accumulation as heart failure therapy: Break the communication networks.
    Int J Cardiol. 2021 Mar 29. pii: S0167-5273(21)00565.
    PubMed    


  127. SURKOVA E, Dimopoulos K, Li W
    Reply to: "Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: late manifestation or subclinical predictor of heart failure?"
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00621.
    PubMed     Abstract available


  128. LAINSCAK M, Omersa D, Rosano G, Farkas J, et al
    Pharmacotherapy adherence in patients with heart failure: Easier said than done.
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00555.
    PubMed    


  129. LI Y, Li L, Wang C
    Insulin-like growth factor binding protein 2 might be a novel therapeutic target in the treatment of heart failure.
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00549.
    PubMed    


  130. COHEN S, Liu A, Abrahamowicz M, Brophy JM, et al
    Reply to "Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues".
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00482.
    PubMed    


  131. TANG L, Liu J, Zheng J
    Targeting mitochondrial calcium uniporter in heart failure.
    Int J Cardiol. 2021 Mar 16. pii: S0167-5273(21)00485.
    PubMed    


  132. AL-WAKEEL-MARQUARD N, Seidel F, Herbst C, Kuhnisch J, et al
    Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Int J Cardiol. 2021 Mar 15. pii: S0167-5273(21)00480.
    PubMed     Abstract available


  133. GHIO S, Carluccio E, Scardovi AB, Dini FL, et al
    Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients.
    Int J Cardiol. 2021;327:111-116.
    PubMed     Abstract available


  134. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
    Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2021;327:117-124.
    PubMed     Abstract available


  135. CARLUCCIO E, Pugliese NR, Biagioli P, Zuchi C, et al
    Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis.
    Int J Cardiol. 2021 Mar 10. pii: S0167-5273(21)00383.
    PubMed     Abstract available


  136. HIGUCHI S, Shibata S, Hasegawa H, Matsuda T, et al
    Reply to the letter to the editor: "Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia".
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00458.
    PubMed    


  137. STIENEN S, Ferreira JP, Bar C, Thum T, et al
    Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
    PubMed     Abstract available


  138. BARISON A, Aimo A, Emdin M
    Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00387.
    PubMed    


  139. OLSEN FJ, Biering-Sorensen T
    Right atrial strain: Tapping into a new reservoir of hemodynamic information.
    Int J Cardiol. 2021;326:226-228.
    PubMed    


  140. YEUNG DF, Jiang R, Behnami D, Jue J, et al
    Impact of the updated diastolic function guidelines in the real world.
    Int J Cardiol. 2021;326:124-130.
    PubMed     Abstract available


  141. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;326:156.
    PubMed    


    February 2021
  142. DAVIS MR, Lee CS, Corcoran A, Gupta N, et al
    Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00371.
    PubMed     Abstract available


  143. NITTA G, Inaba O, Kato S, Kono T, et al
    Catheter ablation for atrial fibrillation in patients with congestive heart failure.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00369.
    PubMed     Abstract available


  144. PAOLILLO S, Salvioni E, Perrone Filardi P, Bonomi A, et al
    Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00354.
    PubMed    


  145. VAN DEN EYNDE J, Santens B, Van De Bruaene A, Budts W, et al
    Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: Late manifestation or subclinical predictor of heart failure?
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00368.
    PubMed    


  146. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    PubMed     Abstract available


  147. ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
    Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
    Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
    PubMed     Abstract available


  148. HSIAO FC, Lin CP, Tung YC, Chang PC, et al
    Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
    Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
    PubMed     Abstract available


  149. SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
    Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
    Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
    PubMed     Abstract available


  150. PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
    Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
    PubMed     Abstract available


  151. WANG X, Li X
    Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
    PubMed    


  152. SAKANE K, Kanzaki Y, Hoshiga M
    Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
    PubMed    


  153. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed     Abstract available


  154. PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
    Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
    Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
    PubMed     Abstract available


  155. VERONESE G, Ammirati E, Chen C, Klingel K, et al
    Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
    Int J Cardiol. 2021;324:131-138.
    PubMed     Abstract available


    January 2021
  156. SHETTY S, Malik AH, Ali A, Yang YC, et al
    Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00142.
    PubMed     Abstract available


  157. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available


  158. THEUNS DAMJ, Schaer BA, Caliskan K, Hoeks SE, et al
    Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators.
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00091.
    PubMed     Abstract available


  159. SABOUR S, Ghajari H
    Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00083.
    PubMed    


  160. CAMELI M, Pastore MC, Mandoli GE
    Left atrial strain: A key element for the evaluation of patients with HFpEF.
    Int J Cardiol. 2021;323:197-198.
    PubMed    


  161. SAVIRA F, Edgley AJ, Jucker BM, Willette RN, et al
    RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2021;323:260.
    PubMed    


  162. WEI WY, Lian ZX, Ji Y, Zhang N, et al
    Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;323:205.
    PubMed    


  163. DANI SS, Ganatra S, Vaduganathan M
    Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
    Int J Cardiol. 2021;323:188-191.
    PubMed     Abstract available


  164. IZUMIDA T, Imamura T
    Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34326.
    PubMed    


  165. GALLO-BERNAL S, Calixto CA, Molano-Gonzalez N, Moreno MPD, et al
    Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34329.
    PubMed     Abstract available


  166. KUMAR V, Ryu AJ, Manduca A, Rao C, et al
    Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction.
    Int J Cardiol. 2021;322:278-283.
    PubMed     Abstract available


  167. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
    Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
    Int J Cardiol. 2021;322:272-277.
    PubMed     Abstract available


    December 2020
  168. KAWADA T
    Risk of heart failure and prognosis in patients with atrial fibrillation.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34316.
    PubMed    


  169. IMAMURA T
    Therapeutic strategy for the patients with Takayasu arteritis and heart failure.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34318.
    PubMed    


  170. MAGGIONI AP
    How to appropriately update practicing clinicians on innovations in heart failure therapy waiting for the new version of the guidelines?
    Int J Cardiol. 2020 Dec 24. pii: S0167-5273(20)34290.
    PubMed    


  171. PESTELLI G, Fiorencis A, Trevisan F, Luisi GA, et al
    New measures of right ventricle-pulmonary artery coupling in heart failure: An all-cause mortality echocardiographic study.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34305.
    PubMed     Abstract available


  172. AGARWAL A, Mohanan PP, Kondal D, Baldridge A, et al
    Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.
    Int J Cardiol. 2020 Dec 21. pii: S0167-5273(20)34296.
    PubMed     Abstract available


  173. GAU SY
    Confusing heart failure ischemic etiology prevalence trend and the definition of composite events.
    Int J Cardiol. 2020 Dec 14. pii: S0167-5273(20)34276.
    PubMed    


  174. KWOK CS, Abramov D, Parwani P, Ghosh RK, et al
    Cost of inpatient heart failure care and 30-day readmissions in the United States.
    Int J Cardiol. 2020 Dec 12. pii: S0167-5273(20)34268.
    PubMed     Abstract available


  175. TAKAHAMA H, Izumi C
    Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning?
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34251.
    PubMed    


  176. VOLPE M, Bauersachs J, Bayes-Genis A, Butler J, et al
    Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34242.
    PubMed     Abstract available


  177. SAKANE K, Kanzaki Y, Tsuda K, Maeda D, et al
    Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34235.
    PubMed     Abstract available


  178. CHIONCEL O, Ambrosy AP
    Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34230.
    PubMed    


  179. PAN J, Wang L, Sun Y
    Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2020;320:139.
    PubMed    


    November 2020
  180. FERNANDEZ-MARTINEZ J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, et al
    Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study.
    Int J Cardiol. 2020 Nov 7. pii: S0167-5273(20)34076.
    PubMed     Abstract available


  181. IZUMIDA T, Imamura T
    The optimal transferrin saturation level in patients with heart failure and anemia.
    Int J Cardiol. 2020;318:103.
    PubMed    


  182. WANG Y, Tse G, Roever L, Liu T, et al
    Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
    Int J Cardiol. 2020;318:130.
    PubMed    


    October 2020
  183. SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
    Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
    Int J Cardiol. 2020 Oct 31. pii: S0167-5273(20)34065.
    PubMed    


  184. PUGLIESE NR, Rosada J, Masi S
    Train the brain to preserve the heart: the link between education and heart failure.
    Int J Cardiol. 2020 Oct 30. pii: S0167-5273(20)34057.
    PubMed    


  185. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    PubMed     Abstract available


  186. ZHANG Y, Fan P, Zhang H, Ma W, et al
    Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
    Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
    PubMed     Abstract available


  187. HARIKRISHNAN S, Jeemon P, Ganapathi S, Agarwal A, et al
    Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Int J Cardiol. 2020 Oct 10. pii: S0167-5273(20)33921.
    PubMed     Abstract available


  188. LEE SY, Kim HL, Kim MA, Park JJ, et al
    Obesity paradox in Korean male and female patients with heart failure: A report from the Korean heart failure registry.
    Int J Cardiol. 2020 Oct 9. pii: S0167-5273(20)33922.
    PubMed     Abstract available


  189. SHARMA K, Premchand RK, Mittal S, Monteiro R, et al
    Long-term follow-up of patients with heart failure and reduced ejection receiving autonomic regulation therapy in the ANTHEM-HF pilot study.
    Int J Cardiol. 2020 Oct 7. pii: S0167-5273(20)33902.
    PubMed     Abstract available


  190. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    PubMed     Abstract available


  191. LIAO LZ, Zhuang XD, Zhang SZ, Liao XX, et al
    Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study.
    Int J Cardiol. 2020 Oct 2. pii: S0167-5273(20)33898.
    PubMed     Abstract available


  192. ZHONG P, Yuan M, Kong B, Huang H, et al
    ASK-1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:208.
    PubMed    


  193. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: ASK1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:207.
    PubMed    


    September 2020
  194. SHIBATA N, Kondo T, Kazama S, Kimura Y, et al
    Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.
    Int J Cardiol. 2020 Sep 29. pii: S0167-5273(20)33837.
    PubMed     Abstract available


  195. SURKOVA E, Segura T, Dimopouosl K, Bispo D, et al
    Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle.
    Int J Cardiol. 2020 Sep 25. pii: S0167-5273(20)33832.
    PubMed     Abstract available


  196. AMMIRATI E, Brambatti M, Braun OO, Shah P, et al
    Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Int J Cardiol. 2020 Sep 17. pii: S0167-5273(20)33807.
    PubMed     Abstract available


  197. HIGUCHI S, Hata N, Shibata S, Hirabuki K, et al
    Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
    Int J Cardiol. 2020 Sep 15. pii: S0167-5273(20)33809.
    PubMed     Abstract available


  198. MIAH NT, Faxen UL, Lund LH, Venkateshvaran A, et al
    Diagnostic utility of right atrial reservoir strain to identify elevated right atrial pressure in heart failure.
    Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33742.
    PubMed     Abstract available


  199. BRIDA M
    Heart transplantation in adult congenital heart disease: Importance of timely referral.
    Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33822.
    PubMed    


  200. WU MY, Chen TT, Wu MS, Tu YK, et al
    Radio-contrast medium exposure and Dialysis risk in patients with chronic kidney disease and congestive heart failure: A case-only study.
    Int J Cardiol. 2020 Sep 11. pii: S0167-5273(20)33795.
    PubMed     Abstract available


  201. CHASAPI A, Karogiannis N, Zidros S, Patel K, et al
    Determinants of outcome in patients with heart failure with reduced ejection fraction & secondary mitral regurgitation.
    Int J Cardiol. 2020 Sep 7. pii: S0167-5273(20)33731.
    PubMed     Abstract available


  202. ZHAO J
    Increased cancer risk among patients with heart failure.
    Int J Cardiol. 2020 Sep 7. pii: S0167-5273(20)33739.
    PubMed    


    August 2020
  203. KATBEH A, De Potter T, Geelen P, Di Gioia G, et al
    Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: The role of left atrial strain.
    Int J Cardiol. 2020 Aug 31. pii: S0167-5273(20)33720.
    PubMed     Abstract available


  204. GU J, Pan JA, Lin H, Zhang JF, et al
    Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction.
    Int J Cardiol. 2020 Aug 26. pii: S0167-5273(20)33648.
    PubMed     Abstract available


  205. KRITTAYAPHONG R, Permsuwan U
    Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33544.
    PubMed     Abstract available


  206. COHEN S, Liu A, Wang F, Guo L, et al
    Risk prediction models for heart failure admissions in adults with congenital heart disease.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33566.
    PubMed     Abstract available


  207. MERAS P, Riesgo-Gil F, Rybicka J, Barradas-Pires A, et al
    Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late?
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33574.
    PubMed     Abstract available


  208. FREA S, Pidello S, Boretto P, Rettegno S, et al
    Disproportionate functional mitral regurgitation predicts a favourable response after MitraClip implant in patients with advanced heart failure. Real-world evidence of a new conceptual framework.
    Int J Cardiol. 2020 Aug 11. pii: S0167-5273(20)33553.
    PubMed     Abstract available


  209. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
    Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
    Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
    PubMed     Abstract available


  210. SANDERSON JE, Fang F
    Cardiac cycle time intervals are back again.
    Int J Cardiol. 2020;312:87-88.
    PubMed    


    July 2020
  211. GRASSI G, Seravalle G, Esler M
    Sympathomodulation in congestive heart failure: From drugs to devices.
    Int J Cardiol. 2020 Jul 28. pii: S0167-5273(20)33475.
    PubMed     Abstract available


  212. TADIC M, Cuspidi C
    Sympathetic overdrive in heart failure: What we can do?
    Int J Cardiol. 2020 Jul 26. pii: S0167-5273(20)33483.
    PubMed    


  213. ALKHALIL M, Kearney A, MacElhatton D, Fergie R, et al
    The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
    Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33449.
    PubMed     Abstract available


    June 2020
  214. WANG F, Sterling LH, Liu A, Brophy JM, et al
    Risk of readmission after heart failure hospitalization in older adults with congenital heart disease.
    Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33403.
    PubMed     Abstract available


  215. SAID B, David M, Nadir B, Laurianne LG, et al
    Measurement, consequences and determinants of time to diagnosis in children with new-onset heart failure: A population-based retrospective study (DIACARD study).
    Int J Cardiol. 2020 Jun 15. pii: S0167-5273(20)33385.
    PubMed     Abstract available


  216. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Corrigendum to "Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model" [international journal of cardiology 235(2017),105-113].
    Int J Cardiol. 2020 Jun 10. pii: S0167-5273(20)33267.
    PubMed    


  217. PERCIACCANTE A, Coralli A, Bianucci R
    Corrigendum to "Has Saint Anthony of Padua suffered from congestive heart failure?" International Journal of Cardiology. 2016;221: 110-111.
    Int J Cardiol. 2020 Jun 9. pii: S0167-5273(20)33210.
    PubMed    


  218. GALLO G, Tocci G, Fogacci F, Battistoni A, et al
    Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis.
    Int J Cardiol. 2020 Jun 6. pii: S0167-5273(20)32057.
    PubMed     Abstract available


    May 2020
  219. GUO Z, Liu J, Sun G, Song F, et al
    Post-PCI acute heart failure is an independent predictor of long-term mortality in patients with chronic kidney disease.
    Int J Cardiol. 2020 May 25. pii: S0167-5273(20)30747.
    PubMed     Abstract available


  220. SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
    Prevalence and incidence of various Cancer subtypes in patients with heart failure vs matched controls.
    Int J Cardiol. 2020 May 21. pii: S0167-5273(20)31128.
    PubMed     Abstract available


  221. AKSIT E, Yildirim OT
    Which quantitative test can predict cardiocerebral syndrome in patients with heart failure?
    Int J Cardiol. 2020 May 18. pii: S0167-5273(20)32250.
    PubMed    


  222. MOHAMMADI AB, Sha'rbaf JG, Targhi ST, Mohammadinasab R, et al
    Letter to the Editor Regarding: "The history of the evolution of the knowledge about the diagnosis and the pathogenetic aspects of heart failure: From the Egyptians to James Mackenzie".
    Int J Cardiol. 2020;307:129.
    PubMed    


  223. BESTETTI RB, Cardinalli-Neto A, Couto LB
    Medieval Islamic doctors and chronic heart failure secondary to myocardial disease.
    Int J Cardiol. 2020;307:128.
    PubMed    


  224. GANGA HV, Kanei Y
    Predictors of QRS prolongation in heart failure patients.
    Int J Cardiol. 2020;307:127.
    PubMed    


  225. BOTTO GL, Healey JS
    Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression?
    Int J Cardiol. 2020 May 4. pii: S0167-5273(20)31117.
    PubMed    


  226. ESLAM RB, Ozturk B, Panzer S, Qin H, et al
    Low serum potassium levels and diabetes - An unfavorable combination in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2020 May 4. pii: S0167-5273(20)30719.
    PubMed     Abstract available


  227. BLANCO R, Ambrosio G, Belziti C, Lucas L, et al
    Prognostic value of nt-probnp, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction.
    Int J Cardiol. 2020 May 4. pii: S0167-5273(20)31955.
    PubMed     Abstract available


    April 2020
  228. SAVARESE G, Settergren C, Schrage B, Thorvaldsen T, et al
    Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.
    Int J Cardiol. 2020 Apr 30. pii: S0167-5273(20)31679.
    PubMed     Abstract available


  229. PAOLILLO S, Salvioni E, Filardi PP, Bonomi A, et al
    Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2020 Apr 29. pii: S0167-5273(20)31266.
    PubMed     Abstract available


  230. WANG N, Farrell M, Hales S, Hanvey K, et al
    Prevalence and seasonal variation of precipitants of heart failure hospitalization and risk of readmission.
    Int J Cardiol. 2020 Apr 29. pii: S0167-5273(20)31144.
    PubMed     Abstract available


  231. ELAYI CS, Shohoudi A, Moodie E, Etaee F, et al
    Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(20)30272.
    PubMed     Abstract available


  232. YAP J
    Risk stratification in heart failure: Existing challenges and potential promise.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(20)31672.
    PubMed    


  233. MARENGONI A, Zucchelli A, Vetrano DL, Aloisi G, et al
    Heart failure, frailty, and pre-frailty: A systematic review and meta-analysis of observational studies.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(20)30580.
    PubMed     Abstract available


  234. LEE EC, McNitt S, Martens J, Bruckel JT, et al
    Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(19)34902.
    PubMed     Abstract available


  235. FERRO D, van den Brink H, Amier R, van Buchem M, et al
    Cerebral cortical microinfarcts: A novel MRI marker of vascular brain injury in patients with heart failure.
    Int J Cardiol. 2020 Apr 13. pii: S0167-5273(20)30417.
    PubMed     Abstract available


  236. CORRA U, Giordano A, Piepoli M
    Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool.
    Int J Cardiol. 2020 Apr 11. pii: S0167-5273(19)34943.
    PubMed     Abstract available


  237. GORBACHEVSKI M, Spiesshoefer J, Arzt M, Oldenburg O, et al
    Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30449.
    PubMed     Abstract available


  238. OIKE F, Yamamoto E, Sueta D, Tokitsu T, et al
    Clinical significance of diastolic late mitral annular velocity in heart failure with preserved ejection fraction.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(19)33600.
    PubMed     Abstract available


    March 2020
  239. CANEPA M, Siri G, Puntoni M, Latini R, et al
    Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database.
    Int J Cardiol. 2020 Mar 30. pii: S0167-5273(20)30642.
    PubMed     Abstract available


  240. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
    Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
    Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
    PubMed     Abstract available


  241. LAHEWALA S, Arora S, Tripathi B, Panaich S, et al
    Corrigendum to "Heart failure: Same-hospital vs. different-hospital readmission outcomes" [Int. J. Cardiol. 278 (2019): 186-191].
    Int J Cardiol. 2020 Mar 26. pii: S0167-5273(20)31412.
    PubMed    


  242. SOLER M, Minana G, Santas E, Nunez E, et al
    CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(19)35557.
    PubMed     Abstract available


  243. ALHAKAK AS, Mogelvang R, Schnohr P, Modin D, et al
    The cardiac isovolumetric contraction time is an independent predictor of incident heart failure in the general population.
    Int J Cardiol. 2020 Mar 19. pii: S0167-5273(19)35169.
    PubMed     Abstract available


  244. PRINCIP M, von Kanel R, Ghadri JR, Templin C, et al
    Promising insights from brain perfusion studies in depressed patients with heart failure: Linking the brain with the heart.
    Int J Cardiol. 2020 Mar 13. pii: S0167-5273(20)30370.
    PubMed    


  245. AMBROSY AP, Fitzpatrick JK, Tabada GH, Gurwitz JH, et al
    A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia.
    Int J Cardiol. 2020 Mar 12. pii: S0167-5273(20)30293.
    PubMed     Abstract available


  246. VEENIS JF, Brunner-La Rocca HP, Linssen GCM, Smeele FJJ, et al
    Atrial fibrillation in chronic heart failure patients with reduced ejection fraction: The CHECK-HF registry.
    Int J Cardiol. 2020 Mar 5. pii: S0167-5273(20)30155.
    PubMed     Abstract available


  247. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
    Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
    PubMed     Abstract available


  248. CHUN KH, Kang SM
    Is risk stratification with the Larissa Heart Failure Risk Score useful in Japanese acute heart failure patients?
    Int J Cardiol. 2020 Mar 2. pii: S0167-5273(20)30188.
    PubMed    


    February 2020
  249. CABIATI M, Botta L, Caselli C, Del Ry S, et al
    Transcriptional evaluation of relaxin and endothelin-1 axis in heart failure patients: First evidence of its involvement during left ventricular assist device support.
    Int J Cardiol. 2020 Feb 24. pii: S0167-5273(19)36267.
    PubMed     Abstract available


  250. CUI X, Zhou J, Pivodic A, Dahlstrom U, et al
    Temporal trends in cause-specific readmissions and their risk factors in heart failure patients in Sweden.
    Int J Cardiol. 2020 Feb 22. pii: S0167-5273(20)30270.
    PubMed     Abstract available


  251. PASTORE MC, Mandoli GE, Mondillo S, Cameli M, et al
    Authors' response to "Utility of ACUTE-HF score in patients with acute heart failure".
    Int J Cardiol. 2020;301:153.
    PubMed    


  252. LIGA R, Gimelli A
    Evaluation of the arrhythmic risk in the 21st century: is multi-tracer nuclear imaging the answer?
    Int J Cardiol. 2020;301:119-120.
    PubMed    


  253. AOYANAGI H, Nochioka K, Sakata Y, Miura M, et al
    Temporal changes in left ventricular ejection fraction and their prognostic impacts in patients with Stage B heart failure.
    Int J Cardiol. 2020 Feb 15. pii: S0167-5273(19)34208.
    PubMed     Abstract available


  254. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
    Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
    Int J Cardiol. 2020;301:7-13.
    PubMed     Abstract available


  255. LAHUERTA C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, et al
    Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Int J Cardiol. 2020;301:220-225.
    PubMed     Abstract available


  256. CAZZOLI I, Gunturiz-Beltran C, Guarguagli S, Alonso-Gonzalez R, et al
    Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: Trials and tribulations.
    Int J Cardiol. 2020;301:127-134.
    PubMed     Abstract available


  257. WATANABE Y, Nara Y, Hioki H, Kawashima H, et al
    Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: The LOHAS registry.
    Int J Cardiol. 2020 Feb 7. pii: S0167-5273(19)34524.
    PubMed     Abstract available


  258. TAKADA T, Sakata Y, Nochioka K, Miura M, et al
    Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases.
    Int J Cardiol. 2020 Feb 6. pii: S0167-5273(19)34656.
    PubMed     Abstract available


  259. BUNDGAARD JS, Thune JJ, Gislason G, Fosbol EL, et al
    Quality of life and the associated risk of all-cause mortality in nonischemic heart failure.
    Int J Cardiol. 2020 Feb 4. pii: S0167-5273(19)33648.
    PubMed     Abstract available


  260. CICEKCIOGLU H, Cetin M, Duyuler PT, Ozbek K, et al
    Utility of ACUTE-HF score in patients with acute heart failure.
    Int J Cardiol. 2020;300:208.
    PubMed    


  261. LUPON J, Bayes-Genis A
    Response. The ST2-SCD score in ambulatory heart failure patients.
    Int J Cardiol. 2020;300:207.
    PubMed    


  262. MENACHEM JN, Opotowsky AR
    The art of caring for adults with congenital heart disease in the face of imperfect data.
    Int J Cardiol. 2020;300:141-142.
    PubMed    


    January 2020
  263. MADELAIRE C, Gustafsson F, Stevenson LW, Kristensen SL, et al
    Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity.
    Int J Cardiol. 2020 Jan 23. pii: S0167-5273(19)34977.
    PubMed     Abstract available


  264. SONG Y, Li F, Xu Y, Liu Y, et al
    Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction.
    Int J Cardiol. 2020 Jan 21. pii: S0167-5273(19)36000.
    PubMed     Abstract available


  265. SAVARESE G, Jonsson A, Hallberg AC, Dahlstrom U, et al
    Erratum to "Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum" [Int. J. Cardiol. 298 (2019) 59-68].
    Int J Cardiol. 2020 Jan 20. pii: S0167-5273(20)30194.
    PubMed    


  266. JOLOBE OM
    Iron deficiency and heart failure.
    Int J Cardiol. 2020;299:208.
    PubMed    


  267. LUND LH, Savarese G, Dahlstrom U
    Iron deficiency in heart failure.
    Int J Cardiol. 2020;299:207.
    PubMed    


  268. SPEE RF, Niemeijer VM, Schoots T, Tuinenburg A, et al
    High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
    Int J Cardiol. 2020;299:169-174.
    PubMed     Abstract available


  269. LADOUCEUR M
    Arrhythmia and advanced heart failure in complex congenital heart diseases: What should we do?
    Int J Cardiol. 2020 Jan 13. pii: S0167-5273(19)36087.
    PubMed    


  270. BRUNNER-LA ROCCA HP
    What do we need to better understand the role of biomarkers in heart failure?
    Int J Cardiol. 2020 Jan 11. pii: S0167-5273(19)36004.
    PubMed    


  271. SUZUKI H, Matsumoto Y, Sugimura K, Takahashi J, et al
    Impacts of hippocampal blood flow on changes in left ventricular wall thickness in patients with chronic heart failure.
    Int J Cardiol. 2020 Jan 10. pii: S0167-5273(19)34386.
    PubMed     Abstract available


  272. AL-MOHAMMAD A
    Angiotensin (1-12): New insights into heart failure pathogenesis.
    Int J Cardiol. 2020 Jan 10. pii: S0167-5273(19)36104.
    PubMed    


  273. PEPINE CJ, Merz CNB, El Hajj S, Ferdinand KC, et al
    Heart failure with preserved ejection fraction: Similarities and differences between women and men.
    Int J Cardiol. 2020 Jan 9. pii: S0167-5273(20)30123.
    PubMed     Abstract available


  274. BESTETTI RB, Cardinalli-Neto A, Couto LB
    The history of the evolution of the knowledge about the diagnosis and the pathogenetic aspects of heart failure: From the Egyptians to James Mackenzie.
    Int J Cardiol. 2020 Jan 7. pii: S0167-5273(19)35150.
    PubMed     Abstract available


    December 2019
  275. KITAI T, Xanthopoulos A, Tang WHW, Kaji S, et al
    Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure.
    Int J Cardiol. 2019 Dec 28. pii: S0167-5273(19)35400.
    PubMed     Abstract available


  276. BONAVENTURA A, Vecchie A, Costantino S, Paneni F, et al
    MicroRNA-122 in heart failure with reduced ejection fraction: Epiphenomenon or causal?
    Int J Cardiol. 2019 Dec 18. pii: S0167-5273(19)35614.
    PubMed    


  277. MIYOSHI T, Hisamitsu T, Ishibashi-Ueda H, Ikemura K, et al
    Maternal administration of tadalafil improves fetal ventricular systolic function in a Hey2 knockout mouse model of fetal heart failure.
    Int J Cardiol. 2019 Dec 18. pii: S0167-5273(19)32161.
    PubMed     Abstract available


  278. ZHAO L, Gould PA, Ng ACT, Wang WYS, et al
    Cardiac autonomic nerve system and epicardial fat in atrial fibrillation.
    Int J Cardiol. 2019 Dec 17. pii: S0167-5273(19)35677.
    PubMed    


  279. KARIM HMR, Esquinas A, Singha SK
    Morphine therapy in acute heart failure is associated with increased mechanical ventilation and mortality: Adverse dose-dependent effect or inevitable consequence?
    Int J Cardiol. 2019;297:92.
    PubMed    


  280. ZHONG P, Chen M, Kong B, Fu H, et al
    The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular diseases.
    Int J Cardiol. 2019;297:118.
    PubMed    


  281. GRAMEGNA M, Beneduce A, Bertoldi LF, Pagnesi M, et al
    Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
    Int J Cardiol. 2019 Dec 13. pii: S0167-5273(19)35516.
    PubMed     Abstract available


    November 2019
  282. CASPI O, Naami R, Halfin E, Aronson D, et al
    Adverse dose-dependent effects of morphine therapy in acute heart failure.
    Int J Cardiol. 2019 Nov 27. pii: S0167-5273(19)33734.
    PubMed    


  283. PEREIRA J, Chaves V, Tavares S, Albuquerque I, et al
    Systolic function recovery in Heart Failure: Frequency, prognostic impact and predictors.
    Int J Cardiol. 2019 Nov 22. pii: S0167-5273(19)35038.
    PubMed     Abstract available


  284. BARUTAUT M, Fournier P, Peacock WF, Evaristi MF, et al
    Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
    Int J Cardiol. 2019 Nov 18. pii: S0167-5273(18)36065.
    PubMed     Abstract available


  285. CHIONCEL O, Ambrosy AP
    Hyperglycemia and outcomes in acute heart failure - A bittersweet relationship.
    Int J Cardiol. 2019 Nov 18. pii: S0167-5273(19)33854.
    PubMed    


  286. GIRERD N, Bresso E, Devignes MD, Rossignol P, et al
    Insulin-like growth factor binding protein 2: A prognostic biomarker for heart failure hardly redundant with natriuretic peptides.
    Int J Cardiol. 2019 Nov 13. pii: S0167-5273(19)34861.
    PubMed    


  287. KINOSHITA H, Sairaku A, Morishima N, Dohi Y, et al
    Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing.
    Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)31353.
    PubMed     Abstract available


  288. CHOBUFO MD, Khan S, Agbor VN, Rahman E, et al
    10-Year trend in the prevalence and predictors of depression among patients with heart failure in the USA from 2007-2016.
    Int J Cardiol. 2019 Nov 11. pii: S0167-5273(19)33803.
    PubMed     Abstract available


  289. MARCUS G, Shimony S, Stein GY, Matezky S, et al
    Incidence, predictors and prognostic implications of dyspnea at admission among acute coronary syndrome patients without heart failure.
    Int J Cardiol. 2019 Nov 9. pii: S0167-5273(19)32270.
    PubMed     Abstract available


  290. KAWASAKI M, Yamada T, Furukawa Y, Morita T, et al
    Are cardiac sympathetic nerve activity and epicardial adipose tissue associated with atrial fibrillation recurrence after catheter ablation in patients without heart failure?
    Int J Cardiol. 2019 Nov 9. pii: S0167-5273(19)33189.
    PubMed     Abstract available


  291. GU J, Yin ZF, Zhang JF, Wang CQ, et al
    Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.
    Int J Cardiol. 2019 Nov 7. pii: S0167-5273(19)34047.
    PubMed     Abstract available


  292. STOJKOVIC S, Koller L, Sulzgruber P, Hulsmann M, et al
    Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure.
    Int J Cardiol. 2019 Nov 7. pii: S0167-5273(19)33664.
    PubMed     Abstract available


  293. SUNG SH, Chuang SY, Liu WL, Cheng HM, et al
    Hyperuricemia and pulse pressure are predictive of incident heart failure in an elderly population.
    Int J Cardiol. 2019 Nov 6. pii: S0167-5273(19)32684.
    PubMed     Abstract available


  294. SAVVOULIDIS P, Snider JV, Rawal S, Morris AA, et al
    Serum ST2 and hospitalization rates in Caucasian and African American outpatients with heart failure.
    Int J Cardiol. 2019 Nov 6. pii: S0167-5273(19)33300.
    PubMed     Abstract available


    October 2019
  295. DE LA ESPRIELLA R, Bayes-Genis A, Nunez J
    Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind.
    Int J Cardiol. 2019 Oct 31. pii: S0167-5273(19)32668.
    PubMed    


  296. GARCIA R, Boveda S, Defaye P, Sadoul N, et al
    Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)33062.
    PubMed     Abstract available


  297. OLCHANSKI N, Vest AR, Cohen JT, DeNofrio D, et al
    Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission.
    Int J Cardiol. 2019 Oct 24. pii: S0167-5273(19)33286.
    PubMed     Abstract available


  298. AIMO A, Vergaro G, Solal AC, Emdin M, et al
    Scoring frailty in patients hospitalized for heart failure: Impact on prognosis (and decision making, too?).
    Int J Cardiol. 2019 Oct 16. pii: S0167-5273(19)35071.
    PubMed    


  299. LINDGREN MP, Ji J, Smith JG, Sundquist J, et al
    Mortality risks associated with sibling heart failure.
    Int J Cardiol. 2019 Oct 12. pii: S0167-5273(19)30895.
    PubMed     Abstract available


  300. KWOK CS, Zieroth S, Van Spall HGC, Helliwell T, et al
    The Hospital Frailty Risk Score and its association with in-hospital mortality, cost, length of stay and discharge location in patients with heart failure short running title: Frailty and outcomes in heart failure.
    Int J Cardiol. 2019 Oct 9. pii: S0167-5273(19)32961.
    PubMed     Abstract available


  301. VERGARO G, Emdin M, Lupon J
    How a large registry can explain pathophysiology: The case of anemia in the heart failure syndromes.
    Int J Cardiol. 2019 Oct 7. pii: S0167-5273(19)34281.
    PubMed    


  302. CATTADORI G, Baravelli M, Di Marco S, Picozzi A, et al
    Cardiac resynchronization therapy and training in heart failure: A perfect marriage?
    Int J Cardiol. 2019 Oct 5. pii: S0167-5273(19)34303.
    PubMed    


    September 2019
  303. KIUCHI K, Shirakabe A, Kobayashi N, Okazaki H, et al
    Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure.
    Int J Cardiol. 2019 Sep 13. pii: S0167-5273(19)33225.
    PubMed     Abstract available


  304. FARMAKIS D, Agostoni P, Baholli L, Bautin A, et al
    A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
    Int J Cardiol. 2019 Sep 6. pii: S0167-5273(19)32502.
    PubMed     Abstract available


    August 2019
  305. JORGENSEN PG, Schou M, Biering-Sorensen T, Mogelvang R, et al
    An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes.
    Int J Cardiol. 2019;289:119-124.
    PubMed     Abstract available


  306. IMAMURA T
    Optimal patient selection for MitraClip system in the era of continuous-flow left ventricular assist device.
    Int J Cardiol. 2019;288:61.
    PubMed    


  307. GOMES-NETO M, Duraes AR, Carvalho VO
    Reply to letter to editor: "Effects of high-intensity interval training: Risk of bias by definition".
    Int J Cardiol. 2019;288:115.
    PubMed    


  308. VOLTERRANI M, Cice G, Caminiti G, Vitale C, et al
    Response letter to Dr. William's letter to the editor entitled "The CARVIVA HF trial - Is the devil in the detail?" published August 2018.
    Int J Cardiol. 2019;288:114.
    PubMed    


  309. WININGER M
    Decay in mortality rates among landmark cardiovascular trials.
    Int J Cardiol. 2019;288:100.
    PubMed    


  310. FRIGIOLA A
    Impact of a centre and home-based cardiac rehabilitation program on the quality of life of teenagers and young adults with congenital heart disease: the QUALI- REHAB study rationale, design and methods.
    Int J Cardiol. 2019;288:70-71.
    PubMed    


  311. JOLOBE OMP
    Natriuretic peptide levels in constrictive pericarditis.
    Int J Cardiol. 2019;288:116.
    PubMed    


    July 2019
  312. NITTA D, Imamura T
    Does left ventricular assist device implantation really worsen prognosis in status 2 listed patients?
    Int J Cardiol. 2019;287:86.
    PubMed    


  313. BALBI C, Lodder K, Costa A, Moimas S, et al
    Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
    Int J Cardiol. 2019;287:87-95.
    PubMed     Abstract available


  314. OIKAWA T, Sakata Y, Nochioka K, Miura M, et al
    Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.
    Int J Cardiol. 2019 Jul 12. pii: S0167-5273(19)30080.
    PubMed     Abstract available


    June 2019
  315. BACKHAUS SJ, Kowallick JT, Stiermaier T, Lange T, et al
    Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction.
    Int J Cardiol. 2019 Jun 16. pii: S0167-5273(19)30773.
    PubMed     Abstract available


  316. YAMAMOTO H, Kawada T, Shimizu S, Hayama Y, et al
    Acute effects of intravenous carvedilol versus metoprolol on baroreflex-mediated sympathetic circulatory regulation in rats.
    Int J Cardiol. 2019;285:65-71.
    PubMed     Abstract available


  317. BANFI C, Brioschi M, Karjalainen MK, Huusko JM, et al
    Immature surfactant protein-B impairs the antioxidant capacity of HDL.
    Int J Cardiol. 2019;285:53-58.
    PubMed     Abstract available


  318. PERRONE MA, Pieri M, Marchei M, Sergi D, et al
    Serum free light chains in patients with ST elevation myocardial infarction (STEMI): A possible correlation with left ventricle dysfunction.
    Int J Cardiol. 2019 Jun 12. pii: S0167-5273(19)30221.
    PubMed     Abstract available


    May 2019
  319. VENKATESHVARAN A, Manouras A, Kjellstrom B, Lund LH, et al
    The additive value of echocardiographic pulmonary to left atrial global strain ratio in the diagnosis of pulmonary hypertension.
    Int J Cardiol. 2019 May 31. pii: S0167-5273(18)35980.
    PubMed     Abstract available


  320. BALDETTI L, Beneduce A, Pappalardo F
    Primary mechanical unloading in high-risk myocardial infarction: Perspectives in view of a paradigm shift.
    Int J Cardiol. 2019 May 21. pii: S0167-5273(19)31391.
    PubMed     Abstract available


  321. AMMIRATI E, Van De Heyning CM, Musca F, Brambatti M, et al
    Safety of centrifugal left ventricular assist device in patients previously treated with MitraClip system.
    Int J Cardiol. 2019;283:131-133.
    PubMed     Abstract available


    April 2019
  322. GORI M, D'Elia E, Senni M
    Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives.
    Int J Cardiol. 2019;281:158-165.
    PubMed     Abstract available


    March 2019
  323. LI Z, Chen P, Xu J, Yu B, et al
    A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
    Int J Cardiol. 2019;279:122-125.
    PubMed     Abstract available


  324. WANG X, Lu Y, Xie Y, Shen J, et al
    Emerging roles of proteoglycans in cardiac remodeling.
    Int J Cardiol. 2019;278:192-198.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: